spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  DuraSite 

 HSMN NewsFeed - 27 Aug 2015
InSite Vision and QLT Amend Merger Agreement
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2013
InSite Vision Announces Positive Confirmatory Phase 3 Results for BromSite(TM) for the Reduction of Inflammation and Pain after Cataract Surgery
Biopharmaceuticals Drug Delivery Ophthalmology Surgery
 HSMN NewsFeed - 17 Jun 2013
InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Mylan Pharmaceuticals
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 26 Mar 2013
InSite Vision Wins Appeal of Patent Interference Litigation Against the University of California, San Francisco
Devices Ophthalmology Drug Delivery Litigation
 HSMN NewsFeed - 5 Sep 2012
InSite Vision Introduces DuraSite 2(R) Ophthalmic Drug Delivery System
Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 29 Nov 2011
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
Devices Ophthalmology Drug Delivery Litigation
 HSMN NewsFeed - 31 Mar 2009
InSite Vision Receives Regulatory Approval for AzaSite( )in Canada
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 29 May 2008
InSite Vision Signs AzaSite(R) Licensing and Distribution Agreement with Essex Bio-Technology for People's Republic of China
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 20 Dec 2007
InSite Vision Initiates Pivotal Phase 3 Trials for AzaSite Plus(TM)
Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 13 Aug 2007
InSite Vision Announces U.S. Launch of AzaSite(TM) for Ocular Infections
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Apr 2007
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 27 Apr 2007
Inspire Announces FDA Approval Of AzaSite(TM)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 16 Feb 2007
Inspire Licenses AzaSite(TM) For Ocular Infections
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 16 Feb 2007
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 15 Feb 2007
InSite Vision Announces Patent Agreement With Pfizer
Biopharmaceuticals Drug Delivery Ophthalmology Licensing
 HSMN NewsFeed - 29 Jun 2006
InSite Vision Announces Submission of AzaSite(TM) NDA
Biopharmaceuticals Ophthalmology FDA
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
DuraSite
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.